Cha University

This trial is testing a new combination of four drugs for people with advanced bile duct cancer that cannot be removed by surgery. The goal is to see if adding two newer drugs (Nab-paclitaxel and Tislelizumab) to a standard chemotherapy pair can better control the cancer and help…

This study is testing if a simpler medication plan is safe and effective for people who have had a heart attack and received a stent. After the procedure, participants will take just one strong blood thinner (ticagrelor) plus a low-dose anti-inflammatory drug (colchicine), instea…

This early-stage trial is testing a new type of stem cell treatment for people with a newly diagnosed, aggressive brain cancer called glioblastoma. The stem cells are modified to carry a 'suicide gene' and are injected directly into the brain after surgery. The main goal is to se…

This study is testing whether a new AI tool that reads heart scans (ECGs) is as safe and effective as the current standard process for quickly evaluating patients with chest pain in the emergency department. It will involve about 4,670 people who come to the ER with chest pain th…

This study aims to understand why some patients with advanced bile duct cancer respond better than others to a specific two-drug treatment (lenvatinib plus pembrolizumab). Researchers will follow 100 patients receiving this treatment in real-world clinics to see how well it works…

This study is testing whether a simple blood test can be as good as a tissue biopsy at finding specific genetic changes in advanced bile duct cancer. Researchers will enroll 200 patients to see if the blood test results match the traditional tissue test and if they help doctors c…